Key Takeaways
- Florida’s medical cannabis licensing process is slow, with applicants waiting over three years for results.
- The state issued 22 Florida cannabis licenses in September 2026, despite legal challenges and recommended rescoring.
- Florida’s regulators are behind on issuing licenses per state law, which requires more licenses based on patient numbers.
- New licensees face strict compliance calendars and financial obligations before they can operate, creating additional delays.
- The growing patient count highlights a pressing need for timely license issuance to improve access across Florida.
Florida’s medical cannabis program has never moved quickly, and the latest licensing round proves the point all over again. Applicants who submitted paperwork back in April 2023 spent more than three years waiting to find out if they’d won the right to grow, process, and sell medical marijuana in one of the country’s largest state markets. Some are just now getting their answer.
The news first surfaced through Sally Kent Peebles, a Vicente LLP partner who has spent over a decade working Florida’s cannabis regulatory system from the inside. Her breakdown of the Department of Health’s Final Order, laid out exactly how the state got here and what happens next for the winners.
But the part of this story that deserves more attention isn’t just who won. It’s what the state’s own numbers reveal about how far behind Florida’s regulators have fallen, and what that backlog means for the roughly 941,000 patients this program is supposed to serve.
What Is a Florida MMTC License, and Why Did This Round Take Three Years?
A Medical Marijuana Treatment Center, or MMTC, license is Florida’s version of a vertically integrated cannabis permit. One license covers cultivation, processing, and dispensing, meaning a single company handles the plant from seed to sale rather than splitting those functions across separate operators like many other states do.
Florida opened this particular application window in April 2023, and more than 70 companies threw their hats in the ring. The Office of Medical Marijuana Use reviewed the applications and issued 22 Notices of Intent to Award in November 2024, based on a comparative scoring system.
That’s usually where the story would end. In Florida, it’s where the real fight begins. Unsuccessful applicants challenged the scoring almost immediately, kicking the whole process into formal administrative litigation before the Division of Administrative Hearings. What was supposed to be a straightforward award process turned into a multi-year legal battle involving hundreds of exhibits and dozens of witnesses.
Why Regulators Rejected the Judge’s Call for a Rescore
The centerpiece of this legal fight was a three-month evidentiary hearing running from October 2025 through January 2026, presided over by Administrative Law Judge Mary Li Creasy. Her job was to determine whether the Department’s scoring methodology had been applied fairly across all 70-plus applications.
In May 2026, Creasy issued a Recommended Order calling for a rescore, one that could have flipped the outcome entirely. Some of the original 22 winners might have lost their licenses. Some rejected applicants might have won them instead.
The Department of Health said no. Its September 11 Final Order kept the original 22 winners in place and declined to adopt the judge’s recommendation, according to Peebles’s reporting.
That decision isn’t just a footnote. It signals how much discretion Florida regulators retain even after an independent judge weighs in, and it sets up what expects to be a wave of appeals. Unsuccessful applicants now have 30 days to seek judicial review at Florida’s First District Court of Appeal, and attorneys expect someone to request a pause on all licensing. If the court grants that stay, it throws every deal, lease, and investment tied to these 22 licenses back into uncertainty.
The Math Problem: 941,271 Patients and a Formula Florida Keeps Ignoring
Here’s the angle that all the legal drama is burying. Florida law doesn’t leave license counts up to regulator discretion. State statute requires OMMU to issue four new MMTC licenses for every 100,000 patients added above the program’s initial threshold, and it must do so within six months of hitting that mark.
The state’s own OMMU weekly update from September 11, 2026 shows 941,271 active qualified patients. Run that number against the statutory formula and Florida likely owes its market more than the 22 licenses it just approved.
Peebles put it plainly in her comments to MJBizDaily: OMMU has “generally not followed the statute and often waited years” to issue required licenses, and this round of 22 was largely the state “playing catch-up” on a backlog it created.
That’s worth sitting with. Florida isn’t just slow at processing paperwork. Its regulatory body has a track record of missing its own legally mandated deadlines, and even this batch of licenses, three years in the making, may still leave the state short of what its own patient population requires. For an industry that likes to talk about patient access, that’s a real problem hiding behind a headline that sounds like progress.
Winning a License Doesn’t Mean You’re Open for Business
Anyone assuming the Final Order settles things for the 22 winners is missing how unforgiving Florida’s compliance calendar actually is. Within 10 business days of licensure, each new MMTC has to post $5 million in financial assurance, whether that’s a surety bond, an irrevocable letter of credit, or straight cash.
From there, the clock keeps running. Cultivation authorization has to be requested within 180 days. Processing authorization follows at 270 days. Dispensing authorization caps things off at 365 days. Miss any one of those windows and years of work can unravel fast.
There’s a real-world example of what it takes to actually clear this process. LumaLex Law, a Florida cannabis law firm, recently detailed to MMjDaily, the work behind one client’s successful application: over 100 legal agreements, a cultivation facility acquisition in Ruskin, multiple retail leases, and a full capital raise, all before the license was even awarded. That client finished sixth out of 22 winners, which gives some sense of how much capital and legal firepower it takes just to be in contention.
Many original applications relied on 2022 and 2023 commitments from vendors, properties, and financing sources that may no longer be available or affordable three years later. Winners now have to go back and confirm what’s still standing before they can move forward.
What This Means for Florida Patients
For the 941,271 patients relying on this program, more licenses should eventually mean more dispensaries, more competition, and better access, particularly in rural counties where coverage has historically been thin. But “eventually” is doing a lot of work here. Even under the fastest possible timeline, new licensees have up to 365 days before they’re authorized to dispense anything, and that’s assuming no successful appeals slow things down further.
Florida’s medical cannabis market is already worth close to $1.9 billion. Adding new operators to a market this size matters, but only if those operators can clear the bond, the buildout, and the compliance hurdles standing between a license and an open storefront.
Florida issued 22 licenses this month, but the harder work, cultivation buildouts, processing approvals, bond payments, and likely appeals, is only beginning. The bigger question isn’t really about who won. It’s about whether a regulatory agency that admits to falling behind its own statute can actually keep pace going forward, especially with patient numbers still climbing. Anyone with a stake in Florida’s cannabis market, whether a winning applicant, a denied one, or a patient waiting for better access, should keep a close eye on the appeals process over the next 30 days.
Frequently Asked Questions
Florida approved 22 medical marijuana treatment center (MMTC) licenses in a Final Order issued September 11, 2026, closing out an application round that opened in April 2023.
Within 10 business days of licensure, each company must post a $5 million surety bond, letter of credit, or cash with the Florida Department of Health, followed by deadlines for cultivation, processing, and dispensing authorization over the following year.
Administrative Law Judge Mary Li Creasy recommended a rescore in May 2026 that could have changed which companies received licenses, but the Florida Department of Health declined to adopt that recommendation in its Final Order.
Possibly. Florida law requires four new MMTC licenses for every 100,000 patients above the program’s threshold, and with 941,271 active patients as of September 2026, the state may still be behind on what statute requires.
